- Assist the French Finance Department in various activities to deliver a high-quality service to the Department Heads , and financial accounting & reporting in compliance with local and international regulations
- Be a true business partner with all departments in strategic and operational target setting, decision-making, day-to-day management and projects evaluation.
- Ensure consistency of operations with strategy, allocation and optimization of resources, analyze return on investment
- Manage financial controls and operational coordination of Supply Chain/Logistics activities
- Perform analyses and controls, participate in internal audits, and produce financial reports on all activities.
- Lead ad hoc Finance projects
- Controlling, FP&A, Business Planning - Strong financial and analytical and problem solving skills
- General Accounting (French and US GAAP )
- Internal & External Audit.
- Sense of urgency
- Deal with complexity to implement decision, hands on
- Be a true Business Partner
- Excellent analytical skills
- Project & Cross-Functional management
- Excellent team player
- Pro-active, dynamic, build effective relationships
- Master’s degree in business, economics, or finance, preferred chartered accountant
- Controlling and finance experience ( 5 years )
- Auditing experience in a Big 5 ( 2/3 years)
- Biotech/pharma experience in affiliate is a plus
- Excellent user Excel/Access, ERP (Oracle), SAP…) Financial systems (Hyperion Essbase, others) and Powerpoint
- French and English Fluent
- Through cutting-edge science and medicine, our company discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.
- Our company is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
- Our company also manufactures and commercializes biosimilars of advanced biologic.
- Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options.
- Our company was founded in 1978 and today serves patients in nearly 70 countries.
- We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry.
- To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.
- For nearly two decades our company has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world.
- Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease.
- We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer’s disease, Parkinson’s disease, and ALS.
- As we uncover new insights into human biology, our company is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders.
- Our company is revolutionizing biologic manufacturing, developing the industry’s most advanced plants and processes.
- This expertise is used to produce both original innovative therapies and bio similar that expand patient access to lower-cost medicines.
Our Corporate Citizenship
- The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion.
- As a company, we are focused on improving science education and limiting the impact of our company on the environment.